# Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

> **NCT06614816** · PHASE3 · COMPLETED · sponsor: **Southeast University, China** · enrollment: 1200 (actual)

## Conditions studied

- Chickenpox Vaccines

## Interventions

- **BIOLOGICAL:** Oka strain varicella attenuated live vaccine

## Key facts

- **NCT ID:** NCT06614816
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-10
- **Primary completion:** 2021-07-15
- **Final completion:** 2022-06-20
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2024-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614816, "Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06614816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*